Although the current data is compelling showing distinct antitumoral effects with LY294002 (Figure 1A), cyclin D1 expression was not suppressed after PI3-K inhibition (Figure 1B), which has been found to play crucial oncogenic role in KIT-independent GIST (Ou et al., 2019). The gene discussed is CCND1; the disease is gastrointestinal stromal tumor.